Point72 Hong Kong’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,957
Closed -$611K 1839
2022
Q3
$611K Buy
+13,957
New +$677K 0.02% 678
2022
Q2
Sell
-1,347
Closed -$76K 2539
2022
Q1
$76K Buy
1,347
+297
+28% +$15.8K ﹤0.01% 1226
2021
Q4
$55K Sell
1,050
-1,089
-51% -$59.2K ﹤0.01% 1318
2021
Q3
$128K Buy
2,139
+2,078
+3,407% +$128K ﹤0.01% 1279
2021
Q2
$4K Sell
61
-1,374
-96% -$93.8K ﹤0.01% 1815
2021
Q1
$94K Buy
1,435
+729
+103% +$43.7K ﹤0.01% 1167
2020
Q4
$40K Sell
706
-1,619
-70% -$79.6K ﹤0.01% 1289
2020
Q3
$113K Buy
2,325
+2,275
+4,550% +$123K 0.01% 539
2020
Q2
$3K Buy
+50
New +$2.89K ﹤0.01% 1064
2019
Q4
Sell
-170
Closed -$11K 1527
2019
Q3
$11K Sell
170
-303
-64% -$18.9K ﹤0.01% 755
2019
Q2
$28K Buy
+473
New +$27.9K 0.01% 733
2019
Q1
Sell
-18
Closed -$1K 1350
2018
Q4
$1K Buy
+18
New +$1.08K ﹤0.01% 833
2018
Q1
Sell
-30
Closed -$2K 1216
2017
Q4
$2K Sell
30
-192
-86% -$10.9K ﹤0.01% 721
2017
Q3
$12K Buy
+222
New +$14.7K 0.01% 472
2017
Q2
Sell
-88
Closed -$7K 1075
2017
Q1
$7K Buy
+88
New +$6.38K 0.01% 544

Other funds holding NUVA

Point72 Hong Kong's NUVA Position: Q4 2022 in Review

Point72 Hong Kong sold out of NuVasive, Inc. (NUVA) in Q4 2022, closing a stake of 13,957 shares — an estimated $611K sold.

Point72 Hong Kong first reported a position in NUVA in Q1 2017 and held it in 15 quarters. The position peaked at $611K in Q3 2022. 235 funds tracked by Wall St. Rank hold NUVA as of Q4 2022.

  • Point72 Hong Kong reported no remaining NuVasive, Inc. position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 13,957 NuVasive, Inc. shares in Q4 2022, an estimated $611K.
  • Point72 Hong Kong first reported a position in NuVasive, Inc. in Q1 2017 and held it in 15 quarters.
  • Point72 Hong Kong's NuVasive, Inc. position peaked at $611K in Q3 2022.
  • 235 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.